Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Children With Osteogenesis Imperfecta
NCT01799798Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Feb 2013
- Primary completion
- Jan 2015
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in osteogenesis imperfecta (OI), sponsored by University of Cologne. Started Feb 2013; status: completed.
02
Drugs
denosumab
03
Conditions
osteogenesis imperfecta (OI)
Beyond the preview
Go deeper on NCT01799798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01799798.